Literature DB >> 17724469

Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells.

M Sauermann1, O Sahin, H Sültmann, F Hahne, S Blaszkiewicz, M Majety, K Zatloukal, L Füzesi, A Poustka, S Wiemann, D Arlt.   

Abstract

Vacuole membrane protein 1 (Vmp1) is described as a cancer-relevant cell cycle modulator, but the function of this protein and its mode of action in tumor progression are still unknown. In this study, we show that the VMP1 mRNA level is significantly reduced in kidney cancer metastases as compared to primary tumors. Further, VMP1 expression is also decreased in the invasive breast cancer cell lines HCC1954 and MDA-MB-231 as compared to the non-invasive cell lines MCF-12A, T-47D and MCF-7. We show for the first time that Vmp1 is a plasma membrane protein and an essential component of initial cell-cell contacts and tight junction formation. It interacts with the tight junction protein Zonula Occludens-1 and colocalizes in spots between neighboring HEK293 cells. Downregulation of VMP1 by RNAi results in loss of cell adherence, and increases the invasion capacity of the non-invasive kidney cancer cell line Caki-2. In conclusion, our findings establish Vmp1 to be a novel cell-cell adhesion protein and that its expression level determines the invasion and metastatic potential of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17724469     DOI: 10.1038/sj.onc.1210743

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells.

Authors:  Yun Teng; Tissa T Manavalan; Chuan Hu; Svjetlana Medjakovic; Alois Jungbauer; Carolyn M Klinge
Journal:  Toxicol Sci       Date:  2012-10-10       Impact factor: 4.849

2.  MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways.

Authors:  B Nelson Chau; Cuiyan Xin; Jochen Hartner; Shuyu Ren; Ana P Castano; Geoffrey Linn; Jian Li; Phong T Tran; Vivek Kaimal; Xinqiang Huang; Aaron N Chang; Shenyang Li; Aarti Kalra; Monica Grafals; Didier Portilla; Deidre A MacKenna; Stuart H Orkin; Jeremy S Duffield
Journal:  Sci Transl Med       Date:  2012-02-15       Impact factor: 17.956

3.  Association between genetic variants in p53 binding sites and risks of osteosarcoma in a Chinese population: a two-stage case-control study.

Authors:  Jingzhe Zhang; Li Kai; Wenlong Zhang; Yu Yin; Wenjun Wang
Journal:  Cancer Biol Ther       Date:  2018-06-18       Impact factor: 4.742

Review 4.  MicroRNAs as biomarkers for ischemic heart disease.

Authors:  Lucas N L Van Aelst; Stephane Heymans
Journal:  J Cardiovasc Transl Res       Date:  2013-05-29       Impact factor: 4.132

5.  hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration.

Authors:  Kim Moran-Jones; Joan Grindlay; Marc Jones; Ross Smith; Jim C Norman
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

Review 6.  Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.

Authors:  Gordon Greville; Amanda McCann; Pauline M Rudd; Radka Saldova
Journal:  Epigenetics       Date:  2016-09-30       Impact factor: 4.528

7.  TMEM49-related apoptosis and metastasis in ovarian cancer and regulated cell death.

Authors:  Lili Zheng; Lingling Chen; Xuan Zhang; Jingfen Zhan; Jie Chen
Journal:  Mol Cell Biochem       Date:  2016-03-29       Impact factor: 3.396

8.  Novel role of VMP1 as modifier of the pancreatic tumor cell response to chemotherapeutic drugs.

Authors:  Marine Gilabert; Maria Inés Vaccaro; Martin E Fernandez-Zapico; Ezequiel L Calvo; Olivier Turrini; Véronique Secq; Stéphane Garcia; Vincent Moutardier; Gwen Lomberk; Nelson Dusetti; Raul Urrutia; Juan L Iovanna
Journal:  J Cell Physiol       Date:  2013-09       Impact factor: 6.384

9.  Vacuole membrane protein 1 is an endoplasmic reticulum protein required for organelle biogenesis, protein secretion, and development.

Authors:  Javier Calvo-Garrido; Sergio Carilla-Latorre; Francisco Lázaro-Diéguez; Gustavo Egea; Ricardo Escalante
Journal:  Mol Biol Cell       Date:  2008-06-11       Impact factor: 4.138

10.  Non-random integration of the HPV genome in cervical cancer.

Authors:  Martina Schmitz; Corina Driesch; Lars Jansen; Ingo B Runnebaum; Matthias Dürst
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.